Harriet P. Dustan | Academic Influence

Harriet P. Dustan's AcademicInfluence.com Rankings

Harriet P. Dustan

Philosophy

#4891

World Rank

#7563

Historical Rank

Logic

#2299

World Rank

#3263

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Harriet P. Dustan's Degrees

Doctorate Medicine Harvard University

Why Is Harriet P. Dustan Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Harriet Pearson Dustan was an American physician who is known for her pioneering contributions to effective detection and treatment of hypertension. She was the first woman to serve on the Board of Governors of the American Board of Internal Medicine.

(See a Problem?)

Harriet P. Dustan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. (1988) (1028)
The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. (1984) (577)
The heart in hypertension. (1992) (438)
Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. (1972) (413)
Remission of essential hypertension after renal transplantation. (1983) (345)
Renal insufficiency in treated essential hypertension. (1989) (265)
The changing clinical spectrum of primary aldosteronism. (1983) (253)
The Paradox of Beta‐Adrenergic Blockade in Hypertension (1968) (249)
Cardiovascular Actions of Sodium Nitroprusside in Animals and Hypertensive Patients (1955) (244)
Plasma volume in men with essential hypertension. (1968) (233)
Natural history of renal arterial disease. (1968) (218)
Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. (1983) (215)
Re‐Examination of the Hemodynamics of Hypertension (1969) (211)
Rheumatic and febrile syndrome during prolonged hydralazine treatment. (1954) (202)
Hyperdynamic ß-Adrenergic Circulatory State: Increased ß-Receptor Responsiveness (1969) (201)
Plasma volume and chronic hypertension. Relationship to arterial pressure levels in different hypertensive diseases. (1970) (183)
Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness. (1969) (178)
Hyperdynamic beta-adrenergic circulatory state. (1966) (176)
A pathologic-arteriographic correlation of renal arterial disease. (1966) (169)
Dependence of arterial pressure on intravascular volume in treated hypertensive patients. (1972) (156)
Cardiac output and distribution of blood volume in central and peripheral circulations in hypertensive and normotensive man. (1969) (131)
Physiological comparison of labile and essential hypertension. (1970) (127)
Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. (1982) (125)
Mechanisms of hypertension associated with obesity. (1983) (118)
β-Adrenergic Blockade in Diuretic-Treated Patients with Essential Hypertension (1975) (107)
Plasma volume changes with long-term beta-adrenergic blockade. (1971) (105)
Electrocardiogram in evaluation of resistance to antihypertensive therapy. (1977) (102)
Hemodynamic characteristics of primary aldosteronism. (1973) (98)
Peripheral arterial insufficiency. A complication of beta-adrenergic blocking therapy. (1969) (93)
A new, potent antihypertensive drug: preliminary study of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (guanethidine). (1959) (92)
Multifactorial Analysis of Chronic Hypertension Induced by Electrolyte‐Active Steroids in Trained, Unanesthetized Dogs (1977) (91)
NORMAL ARTERIAL PRESSURE IN PATIENTS WITH RENAL ARTERIAL STENOSIS. (1964) (89)
Arteriosclerosis and renal hypertension; indications for aortography in hypertensive patients and results of surgical treatment of obstructive lesions of renal artery. (1957) (89)
II. HEMODYNAMIC ASPECTS OF HYPERTENSION: Physiological Comparison of Labile and Essential Hypertension (1970) (88)
Functional Correlates of Plasma Renin Activity in Hypertensive Patients (1970) (87)
Editorial: Persistence of Normal Blood Pressure after Discontinuing Treatment in Hypertensive Patients (1962) (85)
Remission of essential hypertension after renal transplantation. (1983) (85)
Arterial Pressure Responses to Discontinuing Antihypertensive Drugs (1968) (79)
Mechanisms, diagnosis and treatment of hypertension of renal vascular origin. (1959) (76)
A Progress Report on Hypertension (1981) (75)
Vasodilating drugs: contrasting haemodynamic effects. (1976) (74)
Idiopathic orthostatic hypotension: circulatory dynamics in chronic autonomic insufficiency. (1974) (74)
On the mechanism of suppressed plasma-renin activity during beta-adrenergic blockade with propranolol. (1974) (70)
Volume-dependent essential and steroid hypertension. (1973) (68)
Physiologic characteristics of hypertension. (1972) (68)
An Evaluation of Treatment of Hypertension Associated with Occlusive Renal Arterial Disease (1963) (66)
Correlation of angiography and natural history in evaluation of patients with renovascular hypertension. (1970) (66)
Atherosclerosis Complicating Chronic Hypertension (1974) (65)
Dissociation Between Renin and Arterial Pressure Responses to Beta‐Adrenergic Blockade in Human Essential Hypertension (1975) (65)
Systemic hypertension and the kidney in black patients. (1987) (58)
Enhanced effectiveness of ganglion-blocking agents in hypertensive patients during administration of a saluretic agent (chlorothiazide). (1957) (58)
Orthostatic hypotension: mechanisms and management. (1975) (56)
Excessive Sodium Retention as a Characteristic of Salt‐Sensitive Hypertension (1986) (55)
Hypertension in Obese Patients: Hemodynamic and Volume Studies (1982) (54)
Hyperkinetic heart in severe hypertension: a separate clinical hemodynamic entity. (1975) (54)
Does keloid pathogenesis hold the key to understanding black/white differences in hypertension severity? (1995) (54)
Obesity and hypertension. (1985) (53)
American college of physicians ethics manual.I: History of medical ethics, the physician and the patient, the physician's relationship to other physicians, the physician and society (1984) (52)
Controlling hypertension. A research success story. (1996) (52)
Hypertension and high hematocrit. Another clue to renal arterial disease. (1966) (48)
Vasopressin secretion in normotensive black and white men and women on normal and low sodium diets. (1986) (48)
Plasma volume changes with upright tilt: studies in hypertension and in syncope. (1970) (48)
Hypertensive vascular disease as a consequence of increased arterial pressure; quantitative study in rats with hydralazine-treated renal hypertension. (1958) (46)
Management of hypertensive disease. (1954) (45)
DIAGNOSIS OF RENAL ARTERIAL LESIONS. (1963) (43)
Report of the Joint Committee for Stroke Facilities: VII. Medical and Surgical Management of Stroke (1973) (43)
Selective hypoaldosteronism despite prolonged pre- and postoperative hyperreninemia in primary aldosteronism. (1975) (43)
Evaluation of l-hydrazinophthalazine (apresoline) in treatment of hypertensive disease. (1952) (42)
Neurogenic participation in essential and renovascular hypertension assessed by acute ganglionic blockade: correlation with haemodynamic indices and intravascular volume. (1973) (41)
Renal function in primary aldosteronism. (1956) (38)
The sympathetic nervous system and hypertension in primary aldosteronism. (1985) (34)
Urologic causes of hypertension. I. Hypertension due to renal artery lesions. (1956) (33)
Cardioadrenergic factor in essential hypertension. (1974) (33)
Haemodynamic effects of propranolol in hypertension: a review. (1976) (33)
Left atrial abnormality and ventricular preejection period in hypertension. (1969) (31)
The First Year of Hypertension (1980) (31)
Mecamylamine in treatment of hypertensive disease; observations on an unusual neuromuscular complication. (1956) (30)
Hemodynamics of essential hypertension in young subjects. (1978) (28)
Hemodynamic and functional mechanisms in two renal hypertensions: arterial and pyelonephritis. (1971) (28)
Corcoran Lecture: The Case For or Against Salt in Hypertension (1989) (28)
The prolonged treatment of hypertension with guanethidine. (1961) (27)
Obesity and Hypertension (1980) (26)
Rational therapies for hypertension. Is step 1 of stepped care archaic? (1987) (25)
Growth factors and racial differences in severity of hypertension and renal diseases (1992) (25)
Beta-adrenergic blocking therapy in hypertension: selection of patients. (1970) (25)
ACTH and cortisone in the acute crisis of systemic lupus erythematosus. (1951) (25)
The evaluation of antihypertensive procedures, with particular reference to their effects on blood pressure. (1955) (24)
Norepinephrine Infusion in Normal Subjects and Patients with Essential or Renal Hypertension: Effect on Blood Pressure, Heart Rate, and Plasma Catecholamine Concentrations (1976) (24)
Contribution of cardiac output to renovascular hypertension in man. Relation to surgical treatment. (1973) (24)
Beta-adrenergic blockade in diuretic-treated patients with essential hypertension. (1975) (23)
Hemodynamics of Renal Arterial Diseases and Hypertension (1968) (23)
Report of the Task Force on the Availability of Cardiovascular Drugs to the Medically Indigent. (1992) (23)
Calcium Channel Blockers Potential Medical Benefits and Side Effects (1989) (22)
A comparison of hemodynamic and volume characteristics of obese and non-obese hypertensive patients. (1981) (21)
Obesity-related hypertension: Evaluation of the separate effects of energy restriction and weight reduction on hemodynamic and neuroendocrine status** (1991) (21)
Clinical experience with reserpine (serpasil): a controlled study. (1954) (20)
Subadventitial fibroplasia of the renal artery, a disease of young women. (1967) (19)
Conservative treatment of renovascular hypertension (1966) (19)
Obesity and hypertension in blacks (1990) (19)
Hypertension: A New Journal (1979) (19)
Obesity-related hypertension: evaluation of the separate effects of energy restriction and weight reduction on hemodynamic and neuroendocrine status. (1991) (19)
Relationship of sodium balance to arterial pressure in black hypertensive patients. (1988) (19)
Isolates systolic hypertension: A long-neglected cause of cardiovascular complications (1989) (18)
Aldosterone-producing tumors of the adrenal gland; report of three cases. (1957) (18)
Bretylium tosylate as an antihypertensive drug. (1960) (17)
Selected pathology of the renal artery (1967) (17)
Behavior changes and the prevention of high blood pressure. Workshop II. AHA Prevention Conference III. Behavior change and compliance: keys to improving cardiovascular health. (1993) (17)
Hypertension and obesity. (1991) (17)
Unilateral renal disease and hypertension (1962) (17)
The course of retinopathy in treated malignant hypertension. (1960) (17)
Sequential changes evoked by chlorothiazide in hypertensive patients. (1960) (16)
The role of salt in hypertension. (1984) (16)
Further evaluation of hydralazine in treatment of hypertensive disease. (1954) (15)
Hypertension and hypertensive cardiovascular disease; review of recent observations. (1951) (15)
ATHEROSCLEROTIC COMPLICATIONS IN HYPERTENSIVE DISEASE (1956) (15)
Atherosclerotic complications of hypertensive disease: relation to therapeutic response and to serum protein and to lipoprotein concentrations; preliminary report. (1956) (14)
Cortisone and ACTH in essential hypertension; establishment of renal glycosuria. (1951) (14)
Separated kidney function tests in hypertensive patients. (1958) (13)
Treatment of obesity-associated hypertension. (1991) (13)
Hyperdynamic beta-adrenergic circulatory state. An overview. (1970) (13)
Spironolactone in hypertensive patients. Oligemic and antihypertensive effects. (1961) (13)
Some Aspects of Occlusive Renal Arterial Disease in Man (1962) (13)
Remission of essential hypertension after renal transplantation. Commentaries (2000) (13)
Urinary formaldehydogenic corticoids: normal values and observations in hypertension. (1950) (12)
50th anniversary historical article. Hypertension. (2000) (12)
Causes of inadequate response to antihypertensive drugs. Volume factors. (1983) (12)
Surgical treatment of hypertension due to renal vascular lesions. (1961) (12)
Pathology of renal artery disease. (1966) (11)
Relationship of Sodium Sensitivity and the Sympathetic Nervous System (1985) (11)
Hemodynamic Effects of Diuretics in Hypertension1 (1977) (11)
Sociopolitical and ethical considerations in the treatment of cardiovascular disease in the elderly. (1987) (11)
Similar effects of hydrochlorothiazide and spironolactone on plasma renin activity in essential hypertension. (1972) (11)
Physiologic consequences of renal arterial stenosis. (1969) (10)
CARDIOVASCULAR AND METABOLIC EFFECTS OF CORTISONE, HYDROCORTISONE AND OTHER STEROIDS IN THE RAT (1952) (10)
Research contributions toward prevention of cardiovascular disease. Research related to the underlying mechanisms in hypertension. (1979) (10)
Pulmonary hypertension with diazoxide and minoxidil (1975) (10)
Controlling atherosclerotic renovascular hypertension. (1973) (10)
SOME FACTORS IN RENAL AND RENOPRIVAL HYPERTENSION. (1964) (10)
Renal arterial disease and hypertension. (1997) (9)
Metabolic and nutritional factors in hypertension (1991) (9)
Stenosing renal artery disease in children. Clinicopathologic correlation in 20 surgically treated cases. (1976) (9)
Relationships Among Intravascular Volume, Total Body Sodium, Arterial Pressure, and Vasomotor Tone (1961) (9)
Principles of access to health care. Access to Health Care Task Force, American Heart Association. (1993) (9)
RENAL HYPERTENSIVE SUSPECT. CLINICAL CHARACTERISTICS. (1964) (9)
Gender differences in hypertension. (1996) (9)
Functional interpretation of renal tests. (1955) (9)
Isolated systolic hypertension: a long-neglected cause of cardiovascular complications. (1990) (8)
The relationship of hypertension to coronary, aortic, and iliofemoral atherosclerosis. (1975) (7)
Physiologic regulation of arterial pressure. An overview. (1982) (7)
URINARY FORMALDEHYDOGENIC CORTICOID AS DETERMINED AFTER ENZYMATIC HYDROLYSIS IN NORMAL SUBJECTS AND IN PATIENTS WITH ADRENAL AND HYPER-TENSIVE DISEASE (1953) (7)
The Resistance Arteries (1994) (6)
Diuretics and diet in hypertension. (1961) (6)
Experience with the use of intravenous fat emulsions in the treatment of chronic uremia. (1957) (6)
Use of systolic time intervals in studying hypertension. (1976) (6)
Massive doses of cortisone in the control of acute lupus crisis in systemic lupus erythematosus. (1951) (5)
Task force 1: Scope of the problem (1992) (5)
Diuretics in the treatment of hypertension. (1959) (5)
Diet and diuretics in the treatment of hypertensive cardiovascular disease. (1960) (5)
Renal hypertension. (1959) (5)
Relief of hypertensive headache by intravenous injection of thiocyanate. (1953) (5)
Renovascular hypertension and azotemia. (1984) (5)
Comparison of Effects on Left Ventricular Filling Pressure of Intravenous Nesiritide and High-Dose Nitroglycerin in Patients With Decompensated Heart Failure (2004) (4)
Cardiovascular consequences of obesity. (1992) (4)
Hypertension, race, and renal insufficiency. (1989) (4)
Effects of vasodilators on renal function in severe heart failure. (1980) (4)
WORKSHOP : METABOLIC AND NUTRITIONAL FACTORS IN HYPERTENSION (1991) (4)
Hemodynamic effects of diuretics in hypertension. (1977) (4)
Renal arterial disease and hypertension. An analysis of selective renal arteriography in 1500 consecutive patients. (1968) (4)
4th International Symposium on Resistance (Part 1 of 4) (1994) (4)
Role of nutrition in hypertension and its control--experimental aspects. (1983) (4)
HYPERTONIA OR UNEVENTFUL HIGH BLOOD-PRESSURE (1957) (3)
50th anniversary historical article. Hypertension. (1999) (3)
Essential hypertension: neural considerations. (1987) (3)
Hypertension Revisited After 55 Years: How It Has Changed! (1995) (3)
Nutrition and cardiovascular diseases of women. (1987) (3)
Remission of essential hypertension after renal transplantation. 1983. (2000) (3)
Suppression of renin release by intravascular volume expansion during chronic diuretic treatment. (1974) (3)
Hypertension treatment. Its past and (perhaps) its future. (1996) (3)
Evaluation and therapy of hypertension--1976. (1976) (2)
Chlorothiazide in the treatment of hypertension. (1960) (2)
[Role of sodium in arterial hypertension]. (1968) (2)
PLASMA VOLUME IN HYPERTENSION (1969) (2)
Irvine Page lecture. Legacies of Irvine H. Page. (1990) (2)
Coronary artery disease in women. (1990) (2)
Medical school education in hypertension management: a national survey. (1985) (2)
CENTRAL SOCIETY FOR CLINICAL RESEARCH (1956) (2)
Note on apparatus for determination of urinary formaldehydogenic corticoids. (1951) (2)
SAFETY OF SELECTIVE RENAL ARTERIOGRAPHY (1963) (2)
Medical school education in hypertension management: a national survey. (1985) (2)
Some clinical effects of guanoxan (1966) (2)
Measurement of effective renal plasma flow in congestive heart failure (1981) (2)
Is Potassium Deficiency a Factor in the Pathogenesis and Maintenance of Hypertension? (1983) (2)
An Ethical Consideration of Large-Scale Clinical Trials in Cardiovascular Diseases Report of the Committee on Ethics of the American Heart Association (2005) (1)
A history of the Council for High Blood Pressure Research: the first 50 years. (1997) (1)
Predictions for the future of antihypertensive drug therapy. (1987) (1)
Hypertension and cardiovascular disease in blacks (1992) (1)
Sociopolitical and ethical considerations in the treatment of cardiovascular disease in the elderly. (1987) (1)
Legacies of irvine H. page (1990) (1)
Cardiogenic hypertension. (1978) (1)
A Perspective on the Salt‐Blood Pressure Relation (1991) (1)
Editorial The changing outlook for hypertensives (1963) (1)
Hypertension and its associated vascular diseases (1960) (1)
Differential diagnosis of etiologic types of hypertension. (1971) (1)
Renin in Aldosteronism: Relating Kidney and Adrenal (1985) (1)
Obesity and hypertension (1989) (1)
Treatment of hypertension. (1970) (1)
Reversible hypertension due to renal artery disease. (1957) (1)
George Lyman Duff Memorial Lecture. Atherosclerosis complicating chronic hypertension. (1974) (1)
The Diagnostic and Therapeutic Importance of Plasma Volume in Hypertensive Patients. (1971) (1)
Intractable, severe hypertensive disease; observations on resistance to treatment with current drugs, denervation of the carotid sinuses, hypertensive encephalopathy, and other complications. (1956) (1)
Etiology and pathogenesis of hypertension. (1970) (1)
Volume-dependent essential and steroid hypertension. (1971) (1)
Urinary formaldehydrogenic corticoid as determined after enzymatic hydrolysis in normal subjects and in patients with adrenal and hypertensive disease. (1953) (1)
Renal vasodilator effects of 1-hydrazinophthalazine in hypertensive patients (1953) (1)
Nutrition and hypertension. (1983) (1)
Current hypertension control is just not good enough. (1998) (1)
Irvine Heinly Page - January 7, 1901-June 10, 1991. (1995) (1)
Chlorothiazide in the treatment of hypertension. (1958) (1)
Chronic thiazide therapy in hypertension evidence for persistent contraction of plasma volume and increased plasma renin activity (1969) (1)
The multifaceted aspects of cardiac involvement in hypertension (1989) (1)
Renal Changes in Low Cardiac Output Failure: Improvement with Vasodilators (1981) (0)
Hypertension Physiological Factors Physiologic Regulation of Arterial Pressure An Overview (0)
Second Bristol-Myers Squibb Lifetime Achievement Award in Hypertension. 1991. (1992) (0)
Prevention of hypertension. (1992) (0)
[Renovascular hypertension]. (1968) (0)
OBESITY AND HYPERTENSION (1939) (0)
Plasma volume measurements in hypertension: Diagnostic and therapeutic implications (1970) (0)
[Curable renal hypertension]. (1960) (0)
MEDICAL management of hypertension. (1963) (0)
Treatment of hypertension. (1970) (0)
Etiology and pathogenesis of hypertension. (1970) (0)
Effects of cortisone and ACTH in essential hypertension: Establishment of renal glycosuria (1951) (0)
Etiology and pathogenesis of hypertension. (1970) (0)
Treatment of hypertension. (1970) (0)
The changing outlook for hypertensives. (1963) (0)
News from the American Meart Association (1981) (0)
[Recent advances in the medical treatment of essential arterial hypertension]. (1955) (0)
Etiology and pathogenesis of hypertension. (1970) (0)
Treatment of hypertension. (1960) (0)
A perspective on teaching medical ethics. Report of the Committee on Ethics of the American Heart Association. (1980) (0)
4th International Symposium on Resistance (Part 3 of 4) (1994) (0)
23rd Bethesda conference: access to cardiovascular care. Task Force 1: Scope of the problem. (1992) (0)
[Hypertensive encephalopathy]. (1958) (0)
Treatment of hypertension. (1970) (0)
Research on hypertension. (1962) (0)
Irvine Heinly Page, MD (1991) (0)
Medical Management of Hypertension (1963) (0)
RENAL FUNCTION IN PRIMARY ALDOSTERONISM 1 (0)
ANTIHYPERTENSIVE GANGLIOPLEGIC DRUGS TABLE 1 . Effects of Chlorothiazide ton Cardiac Output and Related Functions (2005) (0)
Average Hemodynamic Data for the Normotensive Volunteer and Three Essential Hypertensive Groups Essential hypertension (2005) (0)
15 – Animal Products and Hypertension (1982) (0)
Landmark perspective: Renin in aldosteronism. Relating kidney and adrenal. (1985) (0)
Position Statement Principles of Access to Health Care Access to Health Care Task Force, American Heart Association (1993) (0)
Routine chest roentgenograms and ECGs in hypertension. (1979) (0)
A 35-year-old black woman with hypokalemia and accelerated hypertension. (1987) (0)
Biobehavioral factors in hypertension (2005) (0)
THE EPIDEMIOLOGY OF HYPERTENSION. By J. Stamler, R. Stamler and T. N. Pullman. Grune & Stratton, New York and London, 1967. 472 pages, $17.50 (1968) (0)
Arterial Hypertension-Thirty-Four Years Ago and Now (1962) (0)
4th International Symposium on Resistance (Part 2 of 4) (1994) (0)
The kidney. (1952) (0)
The Social, Ethical, Economic, and Political Implications of Coronary Heart Disease Prevention in the Elderly. (1996) (0)
Mechanisms in obesity-related high blood pressure. (1984) (0)
HEALTH CARE, MEDICAL RESEARCH, AND HYPERTENSION: DILEMMAS OF PUBLIC POLICY (1978) (0)
When To Hospitalize The Hypertensive Patient (1966) (0)
Women's Health: Nutrition Nutrition and Cardiovascular Diseases of Women (2006) (0)
TiltTestforInvestigating a Neural Component inHypertension ItsCorrelation withClinical Characteristics (1967) (0)
Treatment of hypertension. (1970) (0)
Treatment of hypertension. (1960) (0)
Mechanisms of Hypertension Induced by Electrolyte-Active Steroids (1980) (0)
Book Review Pathophysiology of Hypertension in Blacks (Clinical Physiology Series.) Edited by John C.S. Fray and Janice G. Douglas. 299 pp. New York, Oxford University Press, 1993. $85. 0-19-506720-7 (1993) (0)
Renal hypertension. (1958) (0)
4th International Symposium on Resistance (Part 4 of 4) (1994) (0)
SECONDARY HYPERTENSION: CLINICAL TYPES AND THEIR DIAGNOSIS. (1964) (0)
Mild hypertension: the continuing dilemma of treatment. (1984) (0)
AHA Committee Report The American Heart Association and Community Cardiovascular Health : An Ethical Comment Report of the Committee on Ethics of the American Heart Association (2005) (0)
Etiology and pathogenesis of hypertension. (1970) (0)

This paper list is powered by the following services:

Other Resources About Harriet P. Dustan

en.wikipedia.org

What Schools Are Affiliated With Harriet P. Dustan?

Harriet P. Dustan is affiliated with the following schools:

Image Attributions

Image Source for Harriet P. Dustan